X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Fulford India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs FULFORD INDIA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD FULFORD INDIA STRIDES SHASUN LTD/
FULFORD INDIA
 
P/E (TTM) x 14.1 398.8 3.5% View Chart
P/BV x 1.9 6.2 30.7% View Chart
Dividend Yield % 0.5 0.1 644.0%  

Financials

 STRIDES SHASUN LTD   FULFORD INDIA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-16
FULFORD INDIA
Mar-14
STRIDES SHASUN LTD/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs1,413942 149.9%   
Low Rs848450 188.4%   
Sales per share (Unadj.) Rs353.3691.4 51.1%  
Earnings per share (Unadj.) Rs23.411.5 204.0%  
Cash flow per share (Unadj.) Rs41.015.4 266.9%  
Dividends per share (Unadj.) Rs5.002.00 250.0%  
Dividend yield (eoy) %0.40.3 153.9%  
Book value per share (Unadj.) Rs320.4380.0 84.3%  
Shares outstanding (eoy) m89.353.90 2,291.0%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x3.21.0 317.8%   
Avg P/E ratio x48.360.7 79.6%  
P/CF ratio (eoy) x27.645.3 60.9%  
Price / Book Value ratio x3.51.8 192.6%  
Dividend payout %21.417.4 122.5%   
Avg Mkt Cap Rs m100,9882,714 3,720.4%   
No. of employees `0004.70.4 1,056.3%   
Total wages/salary Rs m4,988505 987.8%   
Avg. sales/employee Rs Th6,730.06,073.0 110.8%   
Avg. wages/employee Rs Th1,063.61,137.4 93.5%   
Avg. net profit/employee Rs Th445.5100.7 442.5%   
INCOME DATA
Net Sales Rs m31,5642,696 1,170.6%  
Other income Rs m1,212125 966.7%   
Total revenues Rs m32,7762,822 1,161.5%   
Gross profit Rs m5,213-46 -11,234.7%  
Depreciation Rs m1,57315 10,347.4%   
Interest Rs m1,80310 18,980.0%   
Profit before tax Rs m3,04954 5,615.5%   
Minority Interest Rs m1270-   
Prior Period Items Rs m-270-   
Extraordinary Inc (Exp) Rs m-3710-   
Tax Rs m68910 7,172.4%   
Profit after tax Rs m2,08945 4,674.3%  
Gross profit margin %16.5-1.7 -959.8%  
Effective tax rate %22.617.7 127.7%   
Net profit margin %6.61.7 399.3%  
BALANCE SHEET DATA
Current assets Rs m35,9491,738 2,068.1%   
Current liabilities Rs m19,402545 3,561.9%   
Net working cap to sales %52.444.3 118.4%  
Current ratio x1.93.2 58.1%  
Inventory Days Days7148 146.3%  
Debtors Days Days1274 2,945.7%  
Net fixed assets Rs m34,47812 289,726.9%   
Share capital Rs m89439 2,291.0%   
"Free" reserves Rs m22,6011,443 1,566.2%   
Net worth Rs m28,6321,482 1,932.0%   
Long term debt Rs m27,4550-   
Total assets Rs m76,5912,077 3,688.1%  
Interest coverage x2.76.7 40.1%   
Debt to equity ratio x1.00-  
Sales to assets ratio x0.41.3 31.7%   
Return on assets %5.12.6 194.7%  
Return on equity %7.33.0 241.9%  
Return on capital %8.24.3 189.7%  
Exports to sales %48.10-   
Imports to sales %14.524.5 59.1%   
Exports (fob) Rs m15,192NA-   
Imports (cif) Rs m4,565659 692.4%   
Fx inflow Rs m16,61217 96,580.8%   
Fx outflow Rs m5,292673 786.2%   
Net fx Rs m11,320-656 -1,725.7%   
CASH FLOW
From Operations Rs m71790 796.2%  
From Investments Rs m-22,284105 -21,304.3%  
From Financial Activity Rs m29,488-14 -209,131.2%  
Net Cashflow Rs m8,073181 4,472.6%  

Share Holding

Indian Promoters % 27.7 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 37.8 3.8 994.7%  
FIIs % 8.6 0.1 8,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 21.2 122.2%  
Shareholders   56,241 4,783 1,175.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  ABBOTT INDIA  PLETHICO PHARMA  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Aug 17, 2017 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 5-YR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS